<?xml version='1.0' encoding='UTF-8'?><xml><records><record><source-app name="HighWire" version="7.x">Drupal-HighWire</source-app><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Canavan, Neil</style></author></authors><secondary-authors><author><style face="normal" font="default" size="100%">Sachs, Gary</style></author></secondary-authors></contributors><titles><title><style face="normal" font="default" size="100%">Antidepressants in Bipolar Disorder: STEP into the Light</style></title><secondary-title><style face="normal" font="default" size="100%">MD Conference Express</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2008</style></year><pub-dates><date><style  face="normal" font="default" size="100%">2008-10-01 00:00:00</style></date></pub-dates></dates><pages><style  face="normal" font="default" size="100%">24-25</style></pages><abstract><style  face="normal" font="default" size="100%">Some of the results from the Systematic Enhancement Treatment Program for Bipolar Disorder [STEP-BD] trial are presented in this article. The primary focus of STEP-BD was to determine whether or not standard antidepressants are effective treatment for bipolar disorder [N Engl J Med 2007].</style></abstract><number><style face="normal" font="default" size="100%">3</style></number><volume><style face="normal" font="default" size="100%">8</style></volume></record></records></xml>